DNA method can provide more effective treatment of childhood cancer

After leukaemia and brain tumours, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for all cases of neuroblastoma in Sweden, and which has led to more effective treatment at individual level.

Neuroblastoma affects around 20 children each year, most of them under the age of two. This form of cancer, which affects the , is particularly unusual: some tumours can regress spontaneously without treatment, while others are highly aggressive and have a despite intensive treatment.

Researchers at the Sahlgrenska Academy, University of Gothenburg have shown that can be used to differentiate the subgroups of this type of cancer, which it is hoped could lead to a more personalized treatment.

"The ultimate scenario would be first to analyze the tumour, and then to introduce medicine that targets the specific properties of that particular tumour," explains Hanna Kryh, who presents the results in her thesis. "In this way, the treatment could be personalized so that patients with a more aggressive form would receive an intensive treatment, while patients with a less aggressive form could be spared unnecessary side-effects. Our studies are a real first step towards such a form of personalized treatment strategy."

The method is already used for all new cases of neuroblastoma in Sweden, in order to make a sounder diagnosis and to place the patient in the appropriate treatment group.

"We have also identified a previously unknown subgroup of neuroblastoma, with a that helps us to investigate which genes are important in terms of tumour development, and may be suitable targets for future treatment."

The researchers hope that the DNA method will be used as a starting point for the development of patient-specific tests that can detect tumour cells in blood or bone marrow samples.

"This would allow us to monitor how well the patient is responding to the treatment, and to detect remaining , that could result in a relapse, at an early stage."

The thesis "Molecular characterization of neuroblastoma tumours – A basis for personalized medicine" was defended in June.

More information: Link to thesis: hdl.handle.net/2077/28956

add to favorites email to friend print save as pdf

Related Stories

Genes associated with aggressive breast cancer

Aug 16, 2010

Researchers at the University of Gothenburg, Sweden, have for the first time identified 12 genes that could be associated with aggressive breast tumours. The discovery could result in more reliable prognoses and better treatment ...

New gene variants increase risk of paediatric cancer

Oct 04, 2012

Two new gene variants have been discovered by researchers from Italy and the United States that increase the risk of neuroblastoma, a paediatric cancer. This discovery was made using automated technology ...

An improved method for calculating tumor growth

Mar 08, 2010

When treating cancer, it is an advantage to know the rate of growth of the cancer tumour. The standard method currently used to determine tumour growth, however, is erroneous. This is the conclusion of scientists at the University ...

Recommended for you

Incomplete HPV vaccination may offer some protection

9 hours ago

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal ...

New imaging agent provides better picture of the gut

10 hours ago

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time ...

User comments